Strategic Acquisition Guerbet’s urological imaging assets were recently sold to Del Medical, indicating potential expansion in specialized imaging capabilities and product lines that could broaden the company’s portfolio to target more urology-focused clinics and hospitals.

Market Expansion Del Medical serves a diverse set of end markets including hospitals, clinics, dental, veterinary, home health, chiropractic, and defense sectors, presenting cross-selling opportunities across multiple outpatient and specialty settings.

Domestic Manufacturing With manufacturing facilities in Chicago and a Roselle headquarters, there is potential to optimize supply chain and shorten lead times for U.S.-based customers, appealing to buyers prioritizing local production and compliance with ISO 13485 standards.

Technology Enablement Existing tech stack emphasizes standards like ISO 13485 and modern software tools; there is room to upsell digital imaging workflow enhancements, cloud-based service offerings, and integration with hospital information systems for radiology departments.

Growth Readiness Revenue tier and recent asset acquisition signal growth momentum; sales conversations can target mid-market hospitals and clinics looking to consolidate imaging assets, with emphasis on upgrade paths, service contracts, and training for new equipment lines.